Wplyw pory roku na stezenie cholesterolu w surowicy

• Autorzy: Andryskowski G , Kowalczyk E. , Blaszczyk-Suszynska J. , Fijalkowski P. , Matysiak J. , Blaszczyk J. , Rapacka E.

Warianty tytułu

EN

Seasonal variation in serum cholesterol levels

• Języki publikacji: PL

Abstrakty

PL

Celem pracy była ocena różnic stężeń cholesterolu (TC), jego frakcji (LDL-C) i triacyloglicerydów (TG) w osoczu badanych pacjentów w okresie jesienno zimowym stosujących dietę hipolipemiczną. Badaniem objęto 47 osób ( 25 kobiet i 22 mężczyzn) w wieku 37-64 lata w związku z leczeniem nadwagi (BMI 27,5±3,9). Wszyscy pacjenci uczestniczący w badaniu od kilu miesięcy stosowali dietę opartą na ograniczeniu zawartości tłuszczów. U 22 osób z tej grupy stwierdzono hiperlipidemię typu II. U pacjentów u których stwierdzono wartości stężeń TC, LDL-C, i TG przekraczające podane zakresy referencyjne zalecono kontrolną wizytę po upływie 12 tygodni. Badanych podzielono na 2 grupy: I: grupa kontrolna: 22 osoby zdrowe (13 kobiet i 9 mężczyzn) z prawidłowymi stężeniami lipidów, w wielu 56,90±6,3 lat. II: 25 chorych z hiperlipidemią typu II (12 kobiet i 13 mężczyzn) w wieku 49,3 lat ±12,3 Po zakończeniu badań u pacjentów z hiperlipidemią typu II stwierdzono znamienny wzrost: 1. TC i LDL-C porównując grupę przed badaniem do grupy po 12 tygodniach obserwacji. 2. LDL-C i TG porównując grupę przed badaniem do grupy kontrolnej. 3. TG porównując grupę po 12 tygodniach obserwacji do grupy kontrolnej.

EN

The aim of the study was to assess the variability of plasma levels of cholesterol, its fractions and triglycerides in patients on hypolipemic diet examined in autumn and winter season. The study comprised 47 patients (25 women and 22 men), aged 37-64 years. All these patients applied the diet based on limitation of fat contents associated with overweight treatment (BMI 27,5±3,9). Type II hyperlipidemia was diagnosed in 22 patients. The patients in whom the values of TC, LDL-C and TG levels exceeded the given reference range, were recommended a check-up after 12 weeks. The examined were divided into 2 groups: I - the control group: 22 healthy subjects (13 women and 9 men) with normal lipid profile, aged 56,90±6,3 years. II - 25 patients with type II hyperlipidemia (12 women and 13 men), aged 49,3±12,3 years. On completion of the study, in patients with type II hyperlipidemia, a significant increase was observed of: 1. TC and LDL - C comparing the group before the examination and after 12 weeks of observation. 2. LDL-C and TG comparing the group before the examination to the control group. 3. TG comparing the group after 12 weeks of observation to the control group.

Słowa kluczowe

PL

surowica krwi; stezenie cholesterolu; choroby czlowieka; dieta; pory roku; hiperlipidemia; cholesterol

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 3-4
• Opis fizyczny: s.1002-1007,rys.,tab.,bibliogr.

Twórcy

autor

Andryskowski G

• Uniwersytet Medyczny, Lodz

autor

Kowalczyk E.

autor

Blaszczyk-Suszynska J.

autor

Fijalkowski P.

autor

Matysiak J.

autor

Blaszczyk J.

autor

Rapacka E.

Bibliografia

• 1. Fuster V., Ryden LE., Asinger RW., Cannom DS., Crijns HJ., Frye RL., Halperin JL., Kay GN., Klein WW., Levy S., McNamara RL., Prystowsky EN., Wann LS.,Wyse DG., Gibbons RJ., Antman EM., Alpert JS., Faxon DP., Fuster V., Gregoratos G., Hiratzka LF., Jacobs AK, Russell RO., Smith SC Jr., Klein WW., Alonso-Garcia A., Blomstrom-Lundqvist C., de Backer G., Flather M., Hradec J., Oto A., Parkhomenko A., Silber S., Torbicki A.: American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society Pacing and Electrophysiology. Circulation. 2001, 23, 104, 2118-50.
• 2. Colditz GA., Willet WC., Stampfer MJ.: Pattems of weight change and their relation to diet in a cohort of healthy women. Am. J. Clin. Nutr. 1990, 51, 1100-1105.
• 3. Pan WH., Chiang BN.: Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan-a unique experience. Atherosclerosis. 1995, 118, 285-95.
• 4. Pudel V., Westenhoefer J.: Dietary and bahavioural principles in the treatment of obesity. International Monitor on Eating Patterns and Weight Control Medicom/Servier 1992, 1, 2-7.
• 5. Romieu J., Willett WC., Stamppfer MJ.: Energy intake and other determinants of relative weight. Am J. Clin. Nutr. 1988, 47, 406-412.
• 6. Miller WC., Lindermann AK., Wallace J., Niederpruem M.: Diet composition, energy intake, and exercise in relation to body fat in men and women. Am. J. Clin. Nutr. 1990 , 52, 426-30.
• 7. Insull W Ir., Henderson MM., Prentice RL., Thompson DJ., Clifford C., Goldman S., Gorbach S., Moskowitz M., Thompson R., Woods M.: Results of a randomized feasibility study of a low-fat diet. Arch Intern Med. 1990, 150, 421-7.
• 8. Kasim SE., Martino S., Kim PN., Khilnani S., Boomer A., Depper J., Reading BA., Haibrun LK.: Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. Am. J. Clin. Nutr. 1993, 57, 146-53.
• 9. Katzel LI., Coon PJ., Dengel J., Goldberg AP.: Effects of an American Heart Association step I diet and weight loss on lipoprotein lipid levels in obese men with silent myocardial ischemia and reduced high-density lipoprotein cholesterol. Metabolism. 1995, 44, 307-14.
• 10. Ockene IS., Chiriboga DE., Stanek EJ 3rd., Harmetz MG., Nicolsi R., Saperia G., Well AD., Freedson P., Merriam PA., Reed G., MaY., Matthews CE., Hebert JR.: Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch. Intn. Med. 2004, 26, 164, 863-70.
• 11. Garde AH., Hansen AM., Skovgaard LT.,Christensen JM.: Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(lc), IgA, prolactin, and free testosterone in healthy women. Clin. Chem. 2000., 46, 551-559.
• 12. Robinson D., Hinohara S., Bevan EA., Takahashi T.: Seasonal variation in serum cholesterol levels in health screening populations from the U.K. and Japan. J. Med. Syst., 1993, 17, 207-211.
• 13. Buxtorf JC., Baudet MF., Martin C.: Seasonal variations of serum lipids and apoproteins. Ann Nutr. Metab. 1988, 32, 68-74.
• 14. Austin MA., Hokanson JE., Brunzell JD.: Charakterization of low density lipoprotein subclasses: metodologie approaches and clinical relevance. Curr. Opin. Lipidol., 1994, 395-403.
• 15. Austin MA., Breslow JL., Hennekens CH.: Low-density lipoprotein subclass patttems and risk of myocardial infarction. JAMA 1988, 260, 1917-1921.
• 16. Austin MA., King MC., Vranizan KM., Krauss RM.: Atherogenic lipoprotein phenotype: a proposed genetic marcer of coronary heart disease risk. Circulation 1990, 82, 495-506.
• 17. Lamarche B., Tchemof A., MoorjaniS.: Small, dense low-desity lipoprotein particles as predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997, 94, 69-75.
• 18.Castelli WP.: Epidemiology of triglycerides: a view from Framingham. Am. J. Cardiol. 1992; 70 (suppl): 3H-9H.
• 19. Fontbonne Aschwege E.: Hypertriglicerydemia as risk factor of coronary hart disease mortality In subjects with impaired glucose tolerance or diabetes. Results from 11-year fallow-up of Paris Prospective Study. Diabetologia 1989, 32, 300-304.
• 20. Jeppesen J., Hein HO., Suadicani P., Gyntlberg F.: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998 ,97, 1029-1036.
• 21.Hokanson JE., Austin MA.: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-229.